|EGFR (Cell-free assay)||ErbB2 (Cell-free assay)|
|1.5 nM||9.0 nM|
|In vitro (25°C)||DMSO||2 mg/mL (4.11 mM)|
|Water||<1 mg/mL (<1 mM)|
|Ethanol||9 mg/mL (18.52 mM)|
|In vivo||30% propylene glycol, 5% Tween 80, 65% D5W||10 mg/mL|
* <1 mg/ml means slightly soluble or insoluble.
* Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.
|Concentration / Solvent Volume / Mass||1 mg||5 mg||10 mg|
|0.1 mM||20.58 mL||102.9 mL||205.8 mL|
|0.5 mM||4.12 mL||20.58 mL||41.16 mL|
|1 mM||2.06 mL||10.29 mL||20.58 mL|
|5 mM||0.41 mL||2.06 mL||4.12 mL|
*The above data is based on the productmolecular weight 485.9. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
|MECHANISM OF ACTION||Inhibitor|
|Storage||at -20°C 3 years Powder|
|Synonyms||CI-1033, CI1033, PD-183805|
AG-1478 (Tyrphostin AG-1478) is an inhibitor of EGFR kinase with an IC50 value of 3 nM.
AG-17 is an inhibitor of EGF receptor kinase with an IC50 value of 460 µM in the human epidermoid carcinoma cell line A431.
AV-412 is an EGFR/HER2 inhibitor that binds to and inhibits the epidermal growth factor receptor (EGFR) and the human epidermal growth facto…
CNX-2006 is a potent, mutant-selective EGFR inhibitor with excellent in vitro activity in cells with activating EGFR mutations, as well as i…
Gefitinib is an EGFR inhibitor, which interrupts signaling through the epidermal growth factor receptor (EGFR) in target cells.
Lapatinib is a dual tyrosine kinase inhibitor which interrupts the HER2 growth receptor pathway.
CP-724714 is an orally available, small molecule, potent HER-2 tyrosine kinase inhibitor that inhibits HER2 kinase (IC50 3.8 ng/ml) .